Valvular Heart Disease in the Community: A European Experience

Current Problems in Cardiology

Volumn 32, Issue 11, 2007, Pages 609-661

  Iung, Bernard ^a   Baron, Gabriel ^a   Tornos, Pilar ^a   Gohlke Bärwolf, Christa ^a   Butchart, Eric G ^a   Vahanian, Alec ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

AGE DISTRIBUTION; ANGIOCARDIOGRAPHY; ANTIBIOTIC PROPHYLAXIS; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; ARTICLE; ASCENDING AORTA; BACTERIAL ENDOCARDITIS; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; EUROPE; EXERCISE TEST; HEALTH SURVEY; HEART CATHETERIZATION; HEART LEFT VENTRICLE FUNCTION; HEART VALVE BIOPROSTHESIS; HEART VALVE SURGERY; HOSPITAL PATIENT; HUMAN; INFECTION PREVENTION; MITRAL VALVE PROSTHESIS; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PRACTICE GUIDELINE; RADIOISOTOPE VENTRICULOGRAPHY; SAMPLE SIZE; SURVIVAL RATE; SURVIVAL TIME; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT PLANNING; VALVULAR HEART DISEASE;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIOVASCULAR SURGICAL PROCEDURES; COMORBIDITY; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 35548998261     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpcardiol.2007.07.002     Document Type: Article

References (49)

1. Nkomo V.T., Gardin J.M., Skelton T.N., et al. Burden of valvular heart diseases: a population-based study. Lancet 368 (2006) 1005-1011
2. Bonow R., Carabello B., DeLeon A., et al. ACC/AHA guidelines for the management of patients with valvular heart disease. Circulation 98 (1998) 1949-1984
3. Bonow R.O., Carabello B.A., Chatterjee K., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 48 (2006) e1-e148
4. Vahanian A., Baumgartner H., Bax J., et al. Guidelines on the management of valvular heart disease. Eur Heart J 28 (2007) 230-268
5. Iung B., Baron G., Butchart E.G., et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J 24 (2003) 1231-1243
6. Tornos P., Iung B., Permanyer-Miralda G., et al. Infective endocarditis in Europe: lessons from the Euro Heart Survey. Heart 91 (2005) 571-575
7. Iung B., Cachier A., Baron G., et al. Decision making in elderly patients with severe aortic stenosis: why are so many denied surgery?. Eur Heart J 26 (2005) 2714-2720
8. Iung B., Messika-Zeitoun D., Cachier A., et al. Actual management of patients with asymptomatic aortic valve disease: how practice fits with guidelines. Am Heart J 153 (2007) 696-703
9. Mirabel M., Iung B., Baron G., et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?. Eur Heart J 28 (2007) 1358-1365
10. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
11. Stewart B.F., Siscovick D., Lind B.K., et al. Clinical factors associated with calcific aortic valve disease: cardiovascular health study. J Am Coll Cardiol 29 (1997) 630-634
12. Rajamannan N.M., Gersh B., and Bonow R.O. Calcific aortic stenosis: from bench to the bedside. Emerging clinical and cellular concepts. Heart 89 (2003) 801-805
13. Rabkin E., Aikawa M., Stone J.R., et al. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 104 (2001) 2525-2532
14. Roberts W.C., Ko J.M., and Hamilton C. Comparison of valve structure, valve weight, and severity of the valve obstruction in 1849 patients having isolated aortic valve replacement for aortic valve stenosis (with or without associated aortic regurgitation) studied at 3 different medical centers in 2 different time periods. Circulation 112 (2005) 3919-3929
15. Rizvi S.F.H., Khan M.A., Kundi A., et al. Current status of rheumatic heart diseases in rural Pakistan. Heart 90 (2004) 394-399
16. Messika-Zeitoun D., Thomson H., Bellamy M., et al. Medical and surgical outcome of tricuspid regurgitation caused by flail leaflets. J Thorac Cardiovasc Surg 128 (2004) 296-302
17. Dare A.J., Vienot J.P., Edwards W.D., et al. New observations on the etiology of aortic valve disease: a surgical pathologic study of 236 cases from 1990. Hum Pathol 24 (1993) 1330-1338
18. Dare A.J., Harrity P.J., Tazelaar H.D., et al. Evaluation of surgically excised mitral valves: revised recommendations based on changing operative procedures in the 1990s. Hum Pathol 24 (1993) 1286-1293
19. Passik C.S., Ackermann D.M., Pluth J.R., et al. Temporal changes in the causes of aortic stenosis: a surgical pathological study of 646 cases. Mayo Clin Proc 62 (1987) 119-123
20. Olsen L.J., Subramanian R., Ackerman D.M., et al. Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years. Mayo Clin Proc 62 (1987) 22-34
21. Lindroos M., Kupari M., Heikkila J., et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 21 (1993) 1220-1225
22. Wolff J.L., Starfield B., and Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 162 (2002) 2269-2276
23. Butchart E.G., Gohlke-Barwolf C., Antunes M.J., et al., Working Groups on Valvular Heart Disease. Thrombosis, and cardiac rehabilitation and exercise physiology, European Society of Cardiology Recommendations for the management of patients after heart valve surgery. Eur Heart J 26 (2005) 2463-2471
24. Monin J.L., Dehant P., Roiron C., et al. Functional assessment of mitral regurgitation by transthoracic echocardiography using standardized imaging planes. J Am Coll Cardiol 46 (2005) 302-309
25. Klocke F.J., Baird M.G., Lorell B.H., et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 42 (2003) 1318-1333
26. Omran H., Schmidt H., Hackenbroch M., et al. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet 361 (2003) 1241-1246
27. Roques F., Nashef S.A., Michel P., et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 15 (1999) 816-823
28. Edwards F.H., Peterson E.D., Coombs L.P., et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 37 (2001) 885-892
29. Hannan E.L., Racz M.J., Jones R.H., et al. Predictors of mortality for patients undergoing cardiac valve replacement in New York State. Ann Thorac Surg 70 (2000) 1212-1218
30. Ambler G., Omar R.Z., Royston P., et al. Generic, simple risk stratification model for heart valve surgery. Circulation 112 (2005) 224-231
31. Lee S.J., Lindquist K., Segal M.R., et al. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 295 (2006) 801-808
32. Kvidal P., Bergström R., Hörte L.G., et al. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 35 (2000) 747-756
33. Sedrakyan A., Vaccarino V., Paltiel A.D., et al. Age does not limit quality of life improvement in cardiac valve surgery. J Am Coll Cardiol 42 (2003) 1215-1217
34. Bouma B.J., van den Brink R.B.A., van der Meulen J.H.P., et al. To operate or not elderly patients with aortic stenosis: the decision and its consequences. Heart 82 (1999) 143-148
35. Pereira J.J., Lauer M.S., Bashir M., et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol 39 (2002) 1356-1363
36. Avierinos J.F., Gersh B.J., Melton III L.J., et al. Natural history of mitral valve prolapse in the community. Circulation 106 (2002) 1355-1361
37. Iung B., Gohlke-Barwolf C., Tornos P., et al. Recommendations on the management of the asymptomatic patient with valvular heart disease. Working Group Report on behalf of the Working Group on Valvular Heart Disease. Eur Heart J 23 (2002) 1253-1266
38. Rahimtoola S.H. Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol 41 (2003) 893-904
39. Vahanian A., and Palacios I.F. Percutaneous approaches to valvular disease. Circulation 109 (2004) 1572-1579
40. US Society of Thoracic Surgeons National Database. http://www.sts.org/section/stsdatabase.
41. National Adult Cardiac Surgical Database Report 1999-2000. The United Kingdom Cardiac Surgical Register. http://www.scts.org/file/NACSDreport2000ukcsr.pdf
42. Iung B. Management of ischaemic mitral regurgitation. Heart 89 (2003) 459-464
43. Hoen B., Alla F., Béguinot I., et al. Changing profile of infective endocarditis-results of a one-year survey in France in 1999. JAMA 288 (2002) 75-81
44. Delahaye F., Goulet V., Lacassin F., et al. Characteristics of infective endocarditis in France in 1991. A 1-year survey. Eur Heart J 16 (1995) 394-401
45. Di Salvo G., Thuny F., Rosenberg V., et al. Endocarditis in the elderly: clinical, echocardiographic, and prognostic features. Eur Heart J 24 (2003) 1576-1583
46. Di Salvo G., Habib G., Pergola V., et al. Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol 37 (2001) 1069-1076
47. Horstkotte D., Follath F., Gutschik E., et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary: the Task Force on infective endocarditis of the European Society of Cardiology. Eur Heart J 25 (2004) 267-276
48. Baddour L.M., Wilson W.R., Bayer A.S., et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia. American Heart Association Endorsed by the Infectious Diseases Society of America. Circulation 111 (2005) e394-e433
49. Habib G. Management of infective endocarditis. Heart 92 (2006) 124-130